Evaluation of S-600918 in Adults With Refractory Chronic Cough
Status:
Completed
Trial end date:
2020-12-28
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the optimal dose of S-600918 in patients
with refractory chronic cough by evaluating the change from baseline in 24-hour cough
frequency (coughs per hour) with S-600918 compared with placebo.